Afuco™ Anti-Human LIPG ADCC Therapeutic Antibody, ADCC Enhanced
Anti-LIPG ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-LIPG antibodies are used to bind and inhibit the enzymatic activity of LIPG, are also useful in assays for detecting or quantitating levels of LIPG. These anti-LIPG antibodies may additionally be used to quantitate LIPG in a tissue sample in order to predict further susceptibility to lowered levels of HDL cholesterol and apolipoprotein AI.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-476CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |
| Target | LIPG |
| Species Reactivity | Human |